时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
研究问题
In parallel, we profiled translational biomarker dynamics in cerebrospinal fluid (CSF), serum, and plasma, quantifying extracellular αSyn species (total, pS129, and MJFR14-positive) by enzyme-linked immunosorbent assay (ELISA).；Our data suggest that LAMP2A gene therapy in the macaque SN is sustainable, attenuates αSyn-related pathology and nigrostriatal dopaminergic neurodegeneration, and improves cognitive outcomes, providing preliminary preclinical evidence in…
方法
Transient transfection of mouse dopaminergic neurons After 7 days of culture, cells were grown until 70% confluence and transfected using Lipofectamine 3000 (Thermo Fisher Scientific, ref.: L3000001).；The cells were seeded at 35,000 cells per well in a black 96-well plate with a transparent bottom and poly- d -lysine–coated surfaces and cultured at 37°C in a humidified air (95%)/CO 2 (5%) atmosphere.；Biological fluid collection Blood serum Blood samples were collected into Vacutainer tubes and allowed to clot for 30 min at room temperature before being centrifuged for 15 min at 1500 g at 4°C.
核心结论
We showed that increasing LAMP2A expression by 15% in the SN of NHP PD animals leads to improved behavioral outcomes, including a reduction in freezing and middle motor activity compared to the control STUFFER group.；We showed that viral-based LAMP2A expression significantly reduces the amount of PK-resistant αSyn in the caudate nucleus in the LAMP2A group compared to the STUFFER group ( ) but not in the putamen, consistent with the results obtained for the pS129-αSyn…；We hypothesized that this positive outcome could be associated with an effect of increased LAMP2A expression on αSyn pathology in cortical areas involved in executive and cognitive control.；This astrocytic reduction in the LAMP2A-injected groups may reflect decreased reactive gliosis secondary to improved neuronal health or to the reduction of extracellular αSyn levels released by neurons evoked by enhanced CMA activity.
局限
However, further studies using more advanced and robust methodologies, such as seed amplification assays (SAAs) or real-time quaking-induced conversion (RT-QuIC), are warranted to validate these results ( – ).；Assessing total αSyn levels in biological fluids as biomarkers is still under debate and brought conflicting results in the field, due to intrinsic biological heterogeneity and protocol differences ( ).
对本项目的价值
本期最高价值：首次在非人灵长类证明 LAMP2A / 分子伴侣介导自噬（CMA）基因治疗可减轻 αSyn 病理与黑质—纹状体变性并改善认知，把「蛋白稳态衰退」从机制假说推进到可转化的体内基因治疗证据 —— 是 CMA 轴立项最直接的参照。 ｜ 价值分 2.7/5（★★★☆☆）
全文来源
PubMed PMC JATS 全文（正文 71,423 字符，已过 DOI 逐字 + 题名指纹双重归属校验）
原文题录
- 英文标题：LAMP2A gene therapy mitigates Parkinson's disease-related pathology in nonhuman primates.
- 期刊与标识：Science advances · PMID 42962009 · DOI 10.1126/sciadv.aeg1787
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。